Table 2.

Demographic, BP, and echocardiographic data for ARVD patients stratified according to renal functiona

Patients with ARVD (n = 79)Preserved Renal FunctionModerate Renal FailureSevere Renal FailureP
n16 (20.3%)35 (44.3%)28 (35.4%)
Age (yr)64.1 ± 7.572.5 ± 5.672.3 ± 7.7<0.005
eGFR (μmol/L)68 ± 1236 ± 719 ± 4<0.001
Proteinuria (g/L)0.1 ± 0.20.3 ± 0.40.6 ± 0.6<0.005
Overall systolic BP (mmHg)134.6 ± 19.1140.1 ± 16.1141.4 ± 22.4NS
Overall diastolic BP (mmHg)71.6 ± 8.973.1 ± 13.772.7 ± 14.0NS
Overall MAP (mmHg)93.9 ± 9.996.9 ± 13.197.1 ± 16.1NS
LVH (%)68.882.878.6NS
LVMI (g/m2)148.9 ± 45.5184.9 ± 69.8188.3 ± 82.5NS
LVEF (%)55.7 ± 14.054.9 ± 9.948.6 ± 11.9NS
LVEDD (cm)5.2 ± 0.65.4 ± 0.95.4 ± 1.2NS
LVEDV (ml)144.0 ± 44.3134.5 ± 35.7166.7 ± 87.7NS
Cholesterol (mmol/L)4.7 ± 1.24.7 ± 0.94.7 ± 1.4NS
Calcium-phosphate product (mmol/L)2.4 ± 0.62.5 ± 0.53.2 ± 0.8<0.001
  • a MAP, mean arterial BP; LVEDD, LV end-diastolic diameter.